Sienna Biopharmaceuticals Announces $40 Million Series B Financing
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Sienna Biopharmaceuticals, Inc., a privately held, clinical stage medical dermatology and...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page